BAX and breast carcinoma: Furthermore, Results showed that Bcl2 and CDK2 levels decreased in the RPL11/RPL5-overexpressing breast cancer cells, whereas the expression of Bax, P21, and P53 increased in MCF7 and ZR-75-1 cells.